FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
Lipoprotein (a) Molarity Assay
K Number: K253069
·
Decision Jun 16, 2026
Classifications
1
FEI Numbers
27
Registration Numbers
27
Same Product Code
42
Applicant Total
11
Review Days
266
Basic Information
- Device Name
- Lipoprotein (a) Molarity Assay
- K Number
- K253069
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.5600
- Medical Specialty
- Immunology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Diazyme Laboratories, Inc.
- Date Received
- September 23, 2025
- Decision Date
- June 16, 2026
- Product Code
- DFC
- Advisory Committee
- Immunology
- Review Advisory Committee
- CH
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| DFC | Lipoprotein, Low-Density, Antigen, Antiserum, Control | FDA class 2 | Immunology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (DFC), ordered by most recent decision date.
Tina-quant Lipoprotein(a) Gen.2 Molarity
FDA 510(k)
FDA Class 2
·Immunology
Lp(a) Ultra
FDA 510(k)
FDA Class 2
·Immunology
Diazyme Lipoprotein (a) Assay
FDA 510(k)
FDA Class 2
·Immunology
ADVIA CHEMISTRY LIPOPROTEIN(A) REAGENT ADVIA CHEMISTRY LIPOPROTEIN(A) CALIBRATOR
FDA 510(k)
FDA Class 2
·Immunology
COBAS C TINA-QUANT LIPOPROTEIN (A) GEN 2 ASSAY MODEL 05852625190; PRECISET LP (A) GEN 2 CALIFRATOR SET MODEL 05852641160
FDA 510(k)
FDA Class 2
·Immunology
DIAZYME LP(A) ASSAY
FDA 510(k)
FDA Class 2
·Immunology
Other Clearances by Diazyme Laboratories, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K252336 | Diazyme Immunoglobulin A Assay; Diazyme Immunoglobulin G Assay; Diazyme Immunoglobulin M Assay | Apr 24, 2026 | Substantially Equivalent |
| K253358 | Diazyme Human Kappa (k) Free Light Chain Assay; Diazyme Human Lambda (¿) Free Light Chain Assay | Dec 19, 2025 | Substantially Equivalent |
| K243462 | Diazyme Colorimetric Lithium Assay | Aug 1, 2025 | Substantially Equivalent |
| K211648 | Diazyme Human Kappa Free Light Chain Assay, Diazyme Human Lambda Free Light Chain Assay | Sep 8, 2022 | Substantially Equivalent |
| K220001 | Diazyme Human Kappa Free Light Chain Assay, Diazyme Human Lambda Free Light Chain Assay | Aug 4, 2022 | Substantially Equivalent |
| K212221 | Diazyme DZ-Lite iFlash Total beta-hCG Assay, Diazyme DZ-Lite iFlash 1800 Chemiluminescence Immunoassay Analyzer | Dec 13, 2021 | Substantially Equivalent |
| K203136 | Diazyme PLAC® Test for Lp-PLA2 Activity | Aug 6, 2021 | Substantially Equivalent |
| K180209 | Diazyme 1,5-AG Assay | Oct 4, 2018 | Substantially Equivalent |
| K181438 | Diazyme Human Kappa Free Light Chain Assay; Diazyme Human Lambda Free Light Chain Assay | Jun 26, 2018 | Substantially Equivalent |
| K180074 | Diazyme Lipoprotein (a) Assay | Mar 22, 2018 | Substantially Equivalent |